SEC Comment Letter 0000000000-22-012338 to Bon Natural Life Ltd (BON)
Bon Natural Life Ltd
Date: Nov. 14, 2022 · CIK: 0001816815 · Accession: 0000000000-22-012338
AI Filing Summary & Sentiment
File numbers found in text: 333-267116
Letter
United States securities and exchange commission logo November 14, 2022 Yongwei Hu Chief Executive Officer Bon Natural Life Limited 25F, Rongcheng Yungu, Keji 3rd Road Xi’an Hi-tech Zone, Xi’an, China Re:Bon Natural Life Limited Amendment No. 2 to Registration Statement on Form F-3 Filed October 31, 2022 File No. 333-267116 Dear Yongwei Hu: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments. Unless we note otherwise, our references to prior comments are to comments in our October 18, 2022 letter. Amendment No. 2 to Registration Statement on Form F-3 Cover Page 1.Revise the cover page to disclose the information set forth in the last sentence of your supplemental response to comment 1 and cross-reference an explanation of the "Negative List." Your disclosure should address how your operations fall outside of the categories covered by the most recent edition of the Negative List, and any relevant guidelines or provisions that informed your determination that the prohibition under the Negative List does not apply to your operations. 2.We acknowledge your response to prior comment 3. However, we note that the cross- reference remains in brackets and it is unclear how the referenced disclosure in the Form 20-F relates to the prospectus disclosure in the document regarding the intercompany
FirstName LastNameYongwei Hu Comapany NameBon Natural Life Limited November 14, 2022 Page 2 FirstName LastName Yongwei Hu Bon Natural Life Limited November 14, 2022 Page 2 transfer. Please revise accordingly. Please contact Abby Adams at 202-551-6902 or Dorrie Yale at 202-551-8776 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Joe Laxague, Esq.
Show Raw Text
United States securities and exchange commission logo
November 14, 2022
Yongwei Hu
Chief Executive Officer
Bon Natural Life Limited
25F, Rongcheng Yungu, Keji 3rd Road
Xi’an Hi-tech Zone, Xi’an, China
Re:Bon Natural Life Limited
Amendment No. 2 to Registration Statement on Form F-3
Filed October 31, 2022
File No. 333-267116
Dear Yongwei Hu:
We have reviewed your amended registration statement and have the following
comments. In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments. Unless we note
otherwise, our references to prior comments are to comments in our October 18, 2022 letter.
Amendment No. 2 to Registration Statement on Form F-3
Cover Page
1.Revise the cover page to disclose the information set forth in the last sentence of your
supplemental response to comment 1 and cross-reference an explanation of the "Negative
List." Your disclosure should address how your operations fall outside of the categories
covered by the most recent edition of the Negative List, and any relevant guidelines or
provisions that informed your determination that the prohibition under the Negative List
does not apply to your operations.
2.We acknowledge your response to prior comment 3. However, we note that the cross-
reference remains in brackets and it is unclear how the referenced disclosure in the Form
20-F relates to the prospectus disclosure in the document regarding the intercompany
FirstName LastNameYongwei Hu
Comapany NameBon Natural Life Limited
November 14, 2022 Page 2
FirstName LastName
Yongwei Hu
Bon Natural Life Limited
November 14, 2022
Page 2
transfer. Please revise accordingly.
Please contact Abby Adams at 202-551-6902 or Dorrie Yale at 202-551-8776 with any
questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Joe Laxague, Esq.